Inactivation of Aconitase by Tetrahydrobiopterin in DArgic Cells: Relevance to PD

다국어 초록 (Multilingual Abstract)

Oxidative damage is thought to be a major cause of the progression of dopamine (DA)rgic neurodegeneration as in Parkinson's disease. We have previously reported that tetrahydrobiopterin (BH4), an endogenous molecule required for DA synthesis, exerts oxidative stress to DA-producing cells and facilitates the production of DA quinone. It is known that aconitase, present in both mitochondrial and cytosolic forms, act as an reactive oxygen species (ROS) sensor, and that their inactivation leads to further generation of ROS. In the present study we investigated whether the BH4- associated vulnerability of DA cells might involve aconitase. In DArgic cell line CATH.a, BH4 treatment caused reduction of activity of both mitochondrial and cytosolic aconitases, and this appeared to be due to direct inactivation of the pre-existing enzyme molecules. Although most of the activity reduced by BH4 was increased upon reactivation reaction under a reducing condition, the restoration was not complete, suggesting that irreversible and covalent modification has occurred. The aconitase inactivation was exacerbated in the presence of DA and attenuated in the presence of tyrosine hydroxylase inhibitor a-methyl-p-tyrosine, suggesting the involvement of DA. The degree of inactivation increased when the cells were treated with the quinone reductase inhibitor dicoumarol and decreased in the presence of quinone reductase inducer sulforaphane. Taken together, BH4 appeared to lead to both reversible and irreversible inactivation of aconitase and that this is facilitated by the presence of DA and accumulation of DA quinone.

참고문헌 (Reference)

1 Rouault TA, "The role of iron regulatory proteins in mammalian iron homeostasis and disease" 2 : 406-414, 2006

2 Flint DH, "The inactivation of Fe-S cluster contain- ing hydro-lyases by superoxide" 268 : 22369-22376, 1993

3 Fornstedt B, "The apparent autoxidation rate of catechols in dopaminerich regions of human brains increases with the degree of dep- igmentation of substantia nigra" 1 : 279-295, 1989

4 Fisher DB, "Tetrahydropterin oxidation without hydroxylation catalyzed by rat liver phenylalanine hydroxylase" 248 : 4300-4304, 1973

5 Choi HJ, "Tetrahydrobiopterin is released from and causes preferential death of catecholaminergic cells by oxidative stress" 58 : 633-640, 2000

6 Hausladen A, "Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not" 269 : 29405-29408, 1994

7 Hastings TG, "Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections" 93 : 1956-1961, 1996

8 Longo VD, "Reversible inactivation of superoxide-sensitive aconitase in Abeta1-42-treated neuronal cell lines" 75 : 1977-1985, 2000

9 Han JM, "Protective effect of sulforaphane against dopaminergic cell death" 321 : 249-256, 2007

10 Dunnett SB, "Prospects for new restorative and neuroprotective treatments in parkinson’s disease" 399 : A32-A39, 1999

11 Davis MD, "Products of the tyrosinedependent oxidation of tetrahydrobiopterin by rat liver phenylalanine hydroxylase" 304 : 9-16, 1993

12 Lee SY, "Particular vulnerability of mesencephalic dopaminergic neurons to tetrahydrobiopterin: implications for Parkinson's disease" 25 : 112-120, 2007

13 Cantu D, "Oxidative inactivation of mitochondrial aconitase results in iron and H2O2-mediated neurotoxicity in rat primary mesencephalic cultures" 4 : e7095-, 2009

14 Yan LJ, "Oxidative damage during aging targets mitochondrial aconitase" 94 : 11168-11172, 1997

15 Liang LP, "Mitochondrial oxidative stress and increased seizure susceptibility in Sod2(−/＋) mice" 36 : 542-554, 2004

16 Menzies FM, "Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis" 125 : 1522-1533, 2002

17 Melov S, "Mitochondrial disease in superoxide dismutase 2 mutant mice" 96 : 846-851, 1999

18 Vasquez-Vivar J, "Mitochondrial aconitase is a source of hydroxyl radical. An electron spin resonance investigation" 275 : 14064-14069, 2000

19 Conway KA, "Kinetic stabilization of the alpha-synuclein protofilbril by a dopamine-alpha-synuclein adduct" 294 : 1257-1258, 2001

20 Davis MD, "Kaufman S and Milstien S (1988) The auto-oxidation of tetrahydrobiopterin" 173 : 345-351, 1988

21 Liang LP, "Iron-sulfur enzyme mediated mitochondrial superoxide toxicity in experimental Parkinson’s disease" 90 : 1076-1084, 2004

22 Choi HJ, "Involvement of apoptosis and calcium mobilization in tetrahydrobiopterin-induced dopaminergic cell death" 181 : 281-290, 2003

23 Gardner PR, "Inactivation-reactivation of aconitase in Escherichia coli. A sensitive measure of superoxide radical" 267 : 8757-8763, 1992

24 Choi HJ, "Dopaminedependent cytotoxi- city of tetrahydrobiopterin: A possible mechanism for selective neurodegeneration in Parkinson's disease" 86 : 143-152, 2003

25 Berman SB, "Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson’s disease" 73 : 1127-1137, 1999

26 Li QY, "Dependence of excitotoxic neurodegeneration on mitochondrial aconitase inactivation" 78 : 746-755, 2001

27 Spencer JP, "Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species" 71 : 2112-2122, 1998